Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

5

Revenue 2017

Merck & Co.

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck & Co.'s 2013 sales performance.

Merck

Merck/Pfizer’s cancer immunotherapy latecomer hits a snag

Merck/Pfizer’s cancer immunotherapy latecomer hits a snag

Merck/Pfizer’ s cancer immunotherapy latecomer hits a snag. Bavencio fails a key lung cancer trial. ... First-to-market checkpoint inhibitors Opdivo from Bristol-Myers Squibb and Merck &Co/MSD’s Keytruda (pembrolizumab) are dominating the PD-1/PD-L1

BMS pens massive $3.6bn deal for Nektar cancer immunotherapy

BMS pens massive $3.6bn deal for Nektar cancer immunotherapy drugs, and it will lead the global commercialisation of regimens that include NKTR-214, with Nektar retaining co-marketing rights in the US, major EU markets and Japan. ... For BMS the risk could be worth it as it tries to defend Opdivo from Merck

Finding the patient voice

Finding the patient voice is the co-founder of FindMeCure. 15th February 2018.

Trio of new starters for Wave

Trio of new starters for Wave Roderick Ball, co-owner and director of Wave, said: “As Wave continues to grow I am delighted to have Maria, Ella and Lucy bring their programme management and editorial experience to

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Finding the patient voice
How patients feel and speak about clinical trials...
Six Factors to Consider When Designing Advisory Boards
...
The good, the bad and the ugly
Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 - it’s a trilogy of trends...

Infographics